These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pre-Exposure Prophylaxis Users' Attitudes About Sexually Transmitted Infections and Its Influence on Condom Use: A Mixed-Method Study in Belgium. Rotsaert A, Nöstlinger C, Van Landeghem E, Vanbaelen T, Wouters E, Buffel V, Scheerder G, Schim van der Loeff M, Vuylsteke B, Reyniers T. AIDS Patient Care STDS; 2022 Dec; 36(12):483-492. PubMed ID: 36484763 [Abstract] [Full Text] [Related]
23. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis. Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, Stoové MA. Clin Infect Dis; 2018 Aug 16; 67(5):676-686. PubMed ID: 29509889 [Abstract] [Full Text] [Related]
24. Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004-2014. Chen YH, Snowden JM, McFarland W, Raymond HF. AIDS Behav; 2016 Dec 16; 20(12):2791-2797. PubMed ID: 26983951 [Abstract] [Full Text] [Related]
25. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L, ANRS IPERGAY Study Group. Lancet HIV; 2017 Sep 16; 4(9):e402-e410. PubMed ID: 28747274 [Abstract] [Full Text] [Related]
28. The relationship between HIV pre-exposure prophylaxis, sexually transmitted infections, and antimicrobial resistance: a qualitative interview study of men who have sex with men. Williams ADN, Wood F, Gillespie D, Couzens Z, Hughes K, Hood K. BMC Public Health; 2022 Nov 29; 22(1):2222. PubMed ID: 36447181 [Abstract] [Full Text] [Related]
30. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi. Maseko B, Hill LM, Phanga T, Bhushan N, Vansia D, Kamtsendero L, Pettifor AE, Bekker LG, Hosseinipour MC, Rosenberg NE. PLoS One; 2020 Nov 29; 15(1):e0226062. PubMed ID: 31929547 [Abstract] [Full Text] [Related]
31. Prevention paradox: Medical students are less inclined to prescribe HIV pre-exposure prophylaxis for patients in highest need. Calabrese SK, Earnshaw VA, Underhill K, Krakower DS, Magnus M, Hansen NB, Mayer KH, Betancourt JR, Kershaw TS, Dovidio JF. J Int AIDS Soc; 2018 Jun 29; 21(6):e25147. PubMed ID: 29939488 [Abstract] [Full Text] [Related]
40. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG, PrEP Brasil Study Team. Lancet HIV; 2018 Mar 29; 5(3):e136-e145. PubMed ID: 29467098 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]